Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thermage is a leading medical aesthetics brand specializing in non-invasive radiofrequency (RF) treatments for skin tightening and contouring. Founded in 1995, the company pioneered the use of monopolar radiofrequency energy to stimulate collagen production in the deep layers of the skin. Its flagship products, including the Thermage FLX and Thermage CPT systems, are used globally by dermatologists and plastic surgeons to treat wrinkles and skin laxity on the face, eyes, and body. The technology works by heating the dermis to induce collagen contraction and remodeling while simultaneously cooling the epidermis for patient comfort. Thermage was a standalone public company until its 2009 merger with Reliant Technologies to form Solta Medical, which is currently a subsidiary of Bausch Health Companies. Today, it remains one of the most recognized names in the aesthetic device industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thermage.